GPT and metabolic dysfunction-associated steatotic liver disease: Contrastingly, ω-3 fatty acid supplementation over the course of 6 months in NAFLD children did not improve the ALT levels [132,176,177], while, in another study, the supplementation of ω-3 fatty acids in children with NAFLD over a period of 18 months improved the ALT levels significantly [70].